Cancer Treatment Research Grants



301 Moved Permanently

Moved Permanently

The document has moved here.




Multidisciplinary Studies of HIV/AIDS and Aging (R01)
This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of...more
Posted On - 2017-06-23


Multidisciplinary Studies of HIV/AIDS and Aging (R21)
This FOA encourages exploratory/developmental research applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical,...more
Posted On - 2017-06-23


Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)
The purpose of this funding opportunity announcement (FOA) is to promote the discovery of novel small molecules that may enhance the ability of the immune system to selectively recognize and attack...more
Posted On - 2017-07-20




Assay development and screening for discovery of chemical probes or therapeutic agents (R01)
Through this funding opportunity announcement (FOA), NIH wishes to stimulate research in discovery and development of novel, small molecules for their potential use in studying disease treatment...more
Posted On - 2017-07-27


Innovative Research in Cancer Nanotechnology (IRCN) (R01)
This Funding Opportunity Announcement (FOA) encourages applications for the development of innovative research projects in cancer nanotechnology. This initiative, to be known as Innovative Research...more
Posted On - 2017-03-30


Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for collaborative R01 projects from multi-disciplinary teams to expand, improve, or transform the reliability...more
Posted On - 2017-04-04


In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)
The purpose of this Funding Opportunity Announcement (FOA) is to: (a) stimulate and accelerate development of novel in vitro and small animal models of HBV/HIV co-infection to accelerate drug...more
Posted On - 2017-05-12




HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)
The purpose of this Funding Opportunity Announcement (FOA) is to fill scientific gaps needed to (a) inform HBV functional cure strategies by furthering our understanding of unique challenges...more
Posted On - 2017-05-12


In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)
The purpose of this Funding Opportunity Announcement (FOA) is to: (a) stimulate and accelerate development of novel in vitro and small animal models of HBV/HIV co-infection to accelerate drug...more
Posted On - 2017-05-12


Dsenyo, founded and designed by Marissa Perry Saints, seeks to help women and artisans working their way out of poverty. Dsenyo is an ethical fashion company that operates as a social enterprise that supports living wage opportunities for workers in Malawi, Africa.




Not for Profit Jobs in Nebraska

  Executive Director Jobs
  Substance Abuse Jobs
  Program Director Jobs
  Executive Director Jobs
  Social Services Jobs